American Integrity Insurance Group, Inc. AII 深 滬
已收盤 08-07 16:00:00 美东时间
21.00
-0.200
-0.94%
華盛通- 最 高21.15
- 今 開21.00
- 成交量 9.22万股
- 最 低 20.72
- 昨 收 21.20
- 總市值 4.11亿
- 52周最高 25.34
- 市盈率 靜 3.71
- 換手率 0.47%
- 52周最低 16.19
- 委 比 -33.33%
- 總股本 1959.08万
- 歷史最高 25.34
- 量 比 0.68
- 振 幅 2.03%
- 歷史最低 14.755
- 每 手 1
- 風險率 1.84%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 潜在涨幅284.62%！Annexon获Needham上调目标价至25美元；多家大行上调美国银行目标价
今日重点评级关注：Needham：维持Annexon"买入"评级，目标价从11美元升至25美元；Benchmark：维持Prenetics Global"买入"评级，目标价从30美元升至40美元
07-16 18:55
Piper Sandler Maintains Overweight on American Integrity, Raises Price Target to $23
Piper Sandler analyst Paul Newsome maintains American Integrity (NYSE:AII) with a Overweight and raises the price target from $20 to $23.
07-15 18:47
Alpha Buying: Wall Street Gave Up. Management Didn't.
One of my favorite investing stories comes from a 1978 John Train article about a Texas rice farmer and hog raiser named Mr. Womack. The story begins with an investor who spent years trying every stock market strategy he could find. He studied charts. He followed the experts. He traded in and out of...
06-18 23:40
美股大行评级 | 潜在涨幅257.14%！瑞杰金融上调InflaRx目标价至9美元，评级升至"强烈买入"
今日重点评级关注：瑞杰金融：上调InflaRx评级至"强烈买入"，目标价从7美元升至9美元；巴克莱：维持Orchestra BioMed Hldgs"超配"评级，目标价从12美元升至13美元
05-14 14:32
Full Transcript: American Integrity Q1 2026 Earnings Call
American Integrity (NYSE:AII) reported first-quarter financial results on Wedne...
05-13 23:53
American Integrity shares are trading lower. The company reported Q1 financial results.
American Integrity shares are trading lower. The company reported Q1 financial ...
05-13 22:47
Citizens Maintains Market Outperform on American Integrity, Lowers Price Target to $25
Citizens analyst Matthew J. Carletti maintains American Integrity (NYSE:AII) with a Market Outperform and lowers the price target from $28 to $25.
05-13 22:11
American Integrity Q1 Adj. EPS $1.03 Beats $0.98 Estimate, Sales $90.931M Beat $90.788M Estimate
American Integrity (NYSE:AII) reported quarterly earnings of $1.03 per share which beat the analyst consensus estimate of $0.98 by 4.04 percent. This is a 99.65 percent decrease over earnings of $292.15 per share from
05-13 04:18
Earnings Scheduled For May 12, 2026
Companies Reporting Before The Bell • Sionna Therapeutics (NASDAQ:SION) is proj...
05-12 19:11
美股大行评级 | 高盛首予PayPay“买入”评级；神经分泌生物科学获花旗等多家机构上调目标价
今日重点评级关注：HC Wainwright & Co.：维持Enlivex"买入"评级，目标价从13美元升至20美元；韦德布什：维持FuboTV"跑赢大市"评级，目标价从3.5美元升至24美元
04-08 18:35
